Paraneoplastic Syndromes Clinical Trials

• The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes
  ClinicalTrials.gov Identifier: NCT00327236 - Recruiting
  Paraneoplastic Syndromes
  
• Immunotherapy of the Paraneoplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00378326 - Recruiting
  Paraneoplastic Syndromes
  
• CC-5013 in Treating Patients With Red Blood Cell Transfusion-Dependent Myelodysplastic Syndromes and a Cytogenetic Abnormality
  ClinicalTrials.gov Identifier: NCT00074126 - Active, not recruiting
  de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; secondary myelodysplastic syndromes
  
• Azacitidine and Arsenic Trioxide in Treating Patients with Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00118196 - Active, not recruiting
  de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; secondary myelodysplastic syndromes
  
• A Survival Study in Patients with High Risk Myelodysplastic Syndromes Comparing Azacitidine versus Conventional Care
  ClinicalTrials.gov Identifier: NCT00071799 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00052832 - Active, not recruiting
  Chronic Myelomonocytic Leukemia; previously treated myelodysplastic syndromes; secondary myelodysplastic syndromes; de novo myelodysplastic syndromes; ...
  
• Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00102687 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Safety and efficacy of CC-5013 monotherapy in subjects with myelodysplastic syndromes associated with a del (5q) cytogenetic abnormality
  ClinicalTrials.gov Identifier: NCT00065156 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Efficacy and safety study of CC-5013 monotherapy in subjects with myelodysplastic syndromes
  ClinicalTrials.gov Identifier: NCT00064974 - Active, not recruiting
  Myelodysplastic Syndromes
  
• CC-5013 in Treating Patients With Transfusion-Dependent Low-Risk or Intermediate-Risk Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00077506 - Active, not recruiting
  Chronic Myelomonocytic Leukemia; previously treated myelodysplastic syndromes; de novo myelodysplastic syndromes; ...
  
• Azacitidine and Etanercept in Treating Patients with Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00118287 - Recruiting
  de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; secondary myelodysplastic syndromes; ...
  
• A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.
  ClinicalTrials.gov Identifier: NCT00551291 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q- Abnormality
  ClinicalTrials.gov Identifier: NCT00179621 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Identifying Characteristics of Bone Marrow Failure Syndromes
  ClinicalTrials.gov Identifier: NCT00315419 - Recruiting
  Bone Marrow Failure Syndromes; Anemia, Aplastic; Myelodysplastic Syndromes; Hemoglobinuria, Paroxysmal; Red-Cell Aplasia, Pure; Purpura, Thrombocytopenic; Leukemia, Lymphocytic
  
• Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00217386 - Active, not recruiting
  Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00017550 - Active, not recruiting
  Refractory Anemia; refractory anemia with excess blasts; de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes
  
• LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes
  ClinicalTrials.gov Identifier: NCT00214630 - Active, not recruiting
  Acute Coronary Syndromes
  
• Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid
  ClinicalTrials.gov Identifier: NCT00437450 - Active, not recruiting
  Anemia in Myelodysplastic Syndromes
  
• Antithymocyte Globulin and Cyclosporine Compared With Standard Therapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00004208 - Active, not recruiting
  Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts; de novo myelodysplastic syndromes; ...
  
• Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00024050 - Active, not recruiting
  Refractory Anemia; refractory anemia with ringed sideroblasts; de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; ...
  
• Infliximab in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00074074 - Active, not recruiting
  refractory anemia with excess blasts; refractory anemia with ringed sideroblasts; Refractory Anemia; de novo myelodysplastic syndromes; ...
  
• Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00104806 - Active, not recruiting
  Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS)
  ClinicalTrials.gov Identifier: NCT00234143 - Recruiting
  Myelodysplastic Syndromes
  
• Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00274781 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Cyclophosphamide and Donor Lymphocytes in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00356928 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)
  ClinicalTrials.gov Identifier: NCT00413114 - Recruiting
  Myelodysplastic Syndromes
  
• Azacitidine, Darbepoetin Alfa, and G-CSF in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00398047 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Bortezomib and Low Dose Cytarabine in the Treatment of High-Risk Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00411905 - Recruiting
  Myelodysplastic Syndromes
  
• A Dose Confirmation Study of Oral Clofarabine for Previously Treated Adult Patients With Intermediate-2 or High Risk Myelodysplastic Syndromes (MDS).
  ClinicalTrials.gov Identifier: NCT00531232 - Recruiting
  Myelodysplastic Syndromes
  
• Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00352001 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00384956 - Recruiting
  Myelodysplastic Syndromes
  
• SCIO-469: Open-Label Study for Patients with Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00113893 - Recruiting
  Myelodysplastic Syndromes
  
• Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00493571 - Recruiting
  Myelodysplastic Syndromes; MDS
  
• Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00503880 - Recruiting
  Myelodysplastic Syndromes
  
• Darbepoetin alfa in Treating Anemic Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00093691 - Recruiting
  Anemia; Fatigue; Myelodysplastic Syndromes
  
• Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00016419 - Active, not recruiting
  Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts; de novo myelodysplastic syndromes; ...
  
• Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00186576 - Active, not recruiting
  Myeloproliferative Disorders; Myelodysplastic Syndromes
  
• Alemtuzumab and Cyclosporine in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00217594 - Recruiting
  Myelodysplastic Syndromes
  
• Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00361296 - Recruiting
  Myelodysplastic Syndromes
  
• Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00382200 - Recruiting
  Myelodysplastic Syndromes
  
• Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00030069 - Recruiting
  Myelodysplastic Syndromes
  
• Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00104962 - Recruiting
  childhood solid tumor; Myelodysplastic Syndromes
  
• Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients
  ClinicalTrials.gov Identifier: NCT00117507 - Active, not recruiting
  Myelodysplastic Syndromes; Iron Overload
  
• A Phase II Trial of Bevacizumab in Myelodysplastic Syndromes (Int-1, Int-2 and High Risk According to IPSS) With Excess of Marrow Blasts
  ClinicalTrials.gov Identifier: NCT00565656 - Recruiting
  Myelodysplastic Syndromes
  
• Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00454480 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Combination Chemotherapy Followed By Donor Umbilical Cord Blood Transplant in Treating Infants With High-Risk Acute Leukemia or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00357565 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Phase IIa Vorinostat Study in Lower Risk Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00486720 - Recruiting
  Myelodysplastic Syndromes; Blood Disease; Bone Marrow Disease
  
• Aflibercept in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00509249 - Recruiting
  Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003827 - Active, not recruiting
  de novo myelodysplastic syndromes; refractory anemia with excess blasts in transformation; refractory anemia with excess blasts; ...
  
• Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00369317 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Sleep Disordered Breathing, APOE, and Lipid Metabolism
  ClinicalTrials.gov Identifier: NCT00046670 - Active, not recruiting
  Sleep Apnea Syndromes; Lung Diseases
  
• Bortezomib in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00262873 - Recruiting
  Myelodysplastic Syndromes
  
• PXD101 in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00357162 - Recruiting
  Myelodysplastic Syndromes
  
• Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)
  ClinicalTrials.gov Identifier: NCT00443339 - Recruiting
  Myelodysplastic Syndromes
  
• Sunitinib in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00451048 - Recruiting
  Myelodysplastic Syndromes
  
• Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00331513 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00380653 - Recruiting
  Leukemias; Myelodysplastic Syndromes
  
• Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00392353 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00020969 - Active, not recruiting
  atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Paricalcitol in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00064376 - Active, not recruiting
  Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes
  
• Chemotherapy With or Without Total-Body Irradiation in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Myelodysplastic Syndromes or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00322101 - Recruiting
  Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Endothelial Progenitor Cells-Capture Stents in Acute Coronary Syndromes
  ClinicalTrials.gov Identifier: NCT00494247 - Recruiting
  Acute Coronary Syndromes; Coronary Heart Disease
  
• Neurocognitive Function in Snoring Children
  ClinicalTrials.gov Identifier: NCT00006321 - Active, not recruiting
  Lung Diseases; Sleep Apnea Syndromes; Neurologic Manifestations
  
• UCN-01 and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00301938 - Recruiting
  Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Low-Dose Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Allogeneic Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorder or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00069992 - Recruiting
  Polycythemia Vera; Essential Thrombocythemia; de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; ...
  
• Familial Aggregation and Natural History of Sleep Apnea
  ClinicalTrials.gov Identifier: NCT00005299 - Active, not recruiting
  Lung Diseases; Sleep Apnea Syndromes
  
• Metoclopramide in Treating Patients With Anemia Due to Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00238134 - Recruiting
  Anemia; Myelodysplastic Syndromes
  
• Azacitidine and Erythropoietin vs Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00379912 - Recruiting
  Myelodysplastic Syndromes
  
• Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland
  ClinicalTrials.gov Identifier: NCT00083798 - Active, not recruiting
  Sleep Apnea Syndromes; Lung Diseases; Insulin Resistance
  
• APPLES: Apnea Positive Pressure Long-Term Efficacy Study
  ClinicalTrials.gov Identifier: NCT00051363 - Active, not recruiting
  Lung Diseases; Sleep Apnea Syndromes; Sleep
  
• Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00072475 - Recruiting
  Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Biological Therapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00005853 - Active, not recruiting
  Myelodysplastic Syndromes
  
• MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00101179 - Active, not recruiting
  adult acute myeloid leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes; secondary acute myeloid leukemia
  
• Epidemiology of Sleep-Disordered Breathing in Adults
  ClinicalTrials.gov Identifier: NCT00005557 - Active, not recruiting
  Lung Diseases; Sleep Apnea Syndromes; Cerebrovascular Disorders
  
• Prevalence and Correlates of Childhood Sleep Apnea
  ClinicalTrials.gov Identifier: NCT00005560 - Active, not recruiting
  Lung Diseases; Sleep Apnea Syndromes
  
• Study of MGCD0103 in Elderly Patients With Previously Untreated Acute Myelogenous Leukemia/High Risk Myelodysplastic Syndromes (MDS) or Adults With Relapsed/Refractory Disease
  ClinicalTrials.gov Identifier: NCT00374296 - Recruiting
  Myelogenous Leukemia, Acute; Myelodysplastic Syndromes
  
• SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00301769 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndromes After a Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00526292 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Fludarabine and Total-Body Irradiation Followed By a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00397813 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Secondary Myelofibrosis
  
• Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Study to Determine the Utility of Wound Vacuum Assisted Closure (VAC) Compared to Conventional Saline Dressing Changes
  ClinicalTrials.gov Identifier: NCT00121537 - Active, not recruiting
  Wounds; Compartment Syndromes
  
• Epoetin alfa With or Without Filgrastim Compared With Blood Transfusions in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003138 - Active, not recruiting
  Anemia; Myelodysplastic Syndromes; Quality of Life
  
• GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00459212 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Study of AP23573 in Patients with Relapsed or Refractory Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00086125 - Active, not recruiting
  Hematologic Malignancies; Leukemia; Myelodysplastic Syndromes; Myeloid Metaplasia; Lymphoma
  
• Study of Proteins Associated with Complex Regional Pain Syndrome
  ClinicalTrials.gov Identifier: NCT00033969 - Active, not recruiting
  Complex Regional Pain Syndromes; Healthy
  
• PKC412 in Patients with Acute Myeloid Leukemia and Patients with Myelodysplastic Syndrome with either Wild Type or Mutated FLT3
  ClinicalTrials.gov Identifier: NCT00045942 - Active, not recruiting
  Acute Myeloid Leukemia; Myelodysplastic Syndromes
  
• Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia
  ClinicalTrials.gov Identifier: NCT00002832 - Active, not recruiting
  Leukemia, Myeloid, Chronic; Myelodysplastic Syndromes; Leukemia, Myeloid; Leukemia, Lymphocytic
  
• A Phase 2 Study to Evaluate the Safety and Effectiveness of Once Weekly or Once Every Two Week Dosing of Epoetin Alfa in Anemic Patients With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
  ClinicalTrials.gov Identifier: NCT00446602 - Not yet recruiting
  Myelodysplastic Syndromes; Anemia
  
• Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00357305 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
  ClinicalTrials.gov Identifier: NCT00398138 - Recruiting
  Leukemia; Lung Cancer; Malignant Mesothelioma; Myelodysplastic Syndromes; Peritoneal Cavity Cancer
  
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002517 - Active, not recruiting
  Myeloid Leukemia; Myelodysplastic Syndromes; Refractory Anemia
  
• Donor Natural Killer Cell Infusion in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00303667 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Low-Intensity Preparation and Allogeneic Transplant in Patients with Cancers of the Blood
  ClinicalTrials.gov Identifier: NCT00146055 - Active, not recruiting
  Myeloma, Plasma-Cell; Lymphoma, Malignant; Myeloproliferative Disorders; Myelodysplastic Syndromes; Waldenstrom''s Macroglobulinemia
  
• Evaluating the Safety of Long Term Dosing of AMG 531 in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)
  ClinicalTrials.gov Identifier: NCT00472290 - Not yet recruiting
  Hematology; MDS; Myelodysplastic Syndromes; Thrombocytopenia
  
• Cholecalciferol in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00068276 - Completed
  previously treated myelodysplastic syndromes; de novo myelodysplastic syndromes; secondary myelodysplastic syndromes; ...
  
• Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00143559 - Active, not recruiting
  Neoplasm, leukemia, myeloid; Lymphoma, Non-Hodgkin; Stem Cell Transplantation; Myelodysplastic Syndromes; Hepatic Cancer
  
• Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00480987 - Recruiting
  Myelodysplastic Syndromes; Acute Myeloid Leukemia; Leukemia
  
• Mechanisms Mediating Cardiovascular Disease in Children with Obstructive Sleep Apnea
  ClinicalTrials.gov Identifier: NCT00059111 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Sleep Apnea Syndromes; Lung Diseases; Hypertension
  
• Umbilical Cord Blood Transplantation in Treating Patients With Severe Aplastic Anemia, Malignant Thymoma, or Myelodysplasia
  ClinicalTrials.gov Identifier: NCT00003336 - Active, not recruiting
  atypical chronic myeloid leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Impact of CPAP on Functional Outcomes in Milder Obstructive Sleep Apnea (CATNAP)
  ClinicalTrials.gov Identifier: NCT00089752 - Recruiting
  Lung Diseases; Sleep Apnea Syndromes; Sleep; Hypertension